Racial Discrepancies in Overall Survival among Men Treated with Radium-223.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000524
Abstract: OBJECTIVE Several recent studies on metastatic castration-resistant prostate cancer (mCRPC) demonstrated an improved overall survival for black vs. white men. Radium-223 is FDA approved for mCRPC based upon a survival benefit in the ALSYMPCA trial,… read more here.
Keywords: treated radium; radium; radium 223; non black ... See more keywords